A skin sample might aid physicians in diagnosing patients with familial amyloid polyneuropathy (FAP) caused by mutations in the TTR gene, according to a study…
News
HATTR-PN
NewsInotersen Seen to Improve Neurological Symptoms, Quality of Life of FAP Patients in Phase 3 Trial
The investigative drug inotersen was shown to significantly reduce neurological progression and improve quality of life in patients with familial amyloid polyneuropathy (FAP) – also…
HATTR-PN
NewsDNA Mutation May Play a Role in Age at Which Familial Amyloid Polyneuropathy Starts, Study Reports
The age at which symptoms of familial amyloid polyneuropathy (FAP) start showing up…
Recent Posts
- Scientists ID blood markers that predict heart risk in ATTR-CM
- Navigating amyloidosis treatment can be challenging for older adults
- Tiny skin biopsies may help diagnose transthyretin amyloidosis: New study
- Early diagnosis, treatment improves survival in ATTR-CM: Study
- FDA lifts clinical hold on Phase 3 trial of nex-z for hATTR-PN